Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06832878
PHASE4

Postoperative Oral Tranexamic Acid in Patients Undergoing Primary Total Joint Arthroplasty

Sponsor: Mayo Clinic

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate the impact of an extended oral Tranexamic Acid regimen on patient reported outcome scores, time to independent ambulation, postoperative range of motion, swelling, change in hemoglobin levels, 90-day complications, readmission and reoperation.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

101

Start Date

2026-06-01

Completion Date

2026-06

Last Updated

2026-02-02

Healthy Volunteers

No

Conditions

Interventions

DRUG

Oral Tranexamic Acid

Subjects will receive a 1.95 g dose of oral TXA at the following timepoints: (1) following ambulation, (2) postoperative day 1, (3) postoperative day 2, and (4) postoperative day 3

Locations (1)

Mayo Clinic in Arizona

Scottsdale, Arizona, United States